Watson 667 (Divalproex Sodium Delayed Release 500 mg)

Pill with imprint Watson 667 is Red, Elliptical / Oval and has been identified as Divalproex Sodium Delayed Release 500 mg. It is supplied by Watson Laboratories, Inc..

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Watson 667

Divalproex Sodium Delayed Release

Imprint

Watson 667

Strength

500 mg

Color

Red

Size

19.00 mm

Shape

Elliptical / Oval

Availability

Prescription only

Drug Class

Fatty acid derivative anticonvulsants

Pregnancy Category

D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine

CSA Schedule

Not a controlled drug

Labeler / Supplier

Watson Laboratories, Inc.

National Drug Code (NDC)

62037-0667

Inactive Ingredients

candelilla wax, cellacefate, silicon dioxide colloidal, croscarmellose sodium, dextrates, FD&C Red No. 40, hydroxypropyl cellulose, hypromellose 2910 (15 mPa.s), ferrosoferric oxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, propylene glycol, silicon dioxide, titanium dioxide, triacetin, aluminum oxide

Note: Inactive ingredients may vary.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Related Images for "Watson 667"

Etodolac

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer